Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

Title
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Authors
Keywords
-
Journal
CURRENT CANCER DRUG TARGETS
Volume 11, Issue 3, Pages 239-253
Publisher
Bentham Science Publishers Ltd.
Online
2011-02-07
DOI
10.2174/156800911794519752

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started